RECRUITING
I'm interested ...!!
Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy
The purpose of the proposed research is to test and validate a Risk Map decision-support system (DSS) for prostate cancer Magnetic Resonance Imaging (MRI) interpretation and identification of clinically significant tumor site(s).
Conditions:
🦠 Prostate Cancer
🗓️ Study Start (Actual) 19 June 2018
🗓️ Primary Completion (Estimated) June 2025
✅ Study Completion (Estimated) December 2025
👥 Enrollment (Estimated) 100
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Chicago, Illinois, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Patients with known or suspected prostate cancer who have been referred to the Department of Radiology at the University of Chicago Medical Center for a diagnostic MRI exam of the prostate, to be followed by an MRI-guided fusion biopsy of the prostate.
    • * Written informed consent.

    Exclusion Criteria:

    • * Patients incapable of giving informed written consent;
    • * Patients who cannot adhere to the experimental protocols for any reason, or have an inability to communicate with the researcher;
    • * Patients with psychiatric disorders that affect their ability to consent for themselves will be excluded and not the entire population of patients with psychiatric disorders.
    • * Prisoners;
    • * Minor children (under the age of 18 years old).
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: MALE
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 19 June 2018
  • First Submitted that Met QC Criteria 11 July 2018
  • First Posted 13 July 2018

Study Record Updates

  • Last Update Submitted that Met QC Criteria 24 August 2023
  • Last Update Posted 25 August 2023
  • Last Verified August 2023
I'm interested ...!!